EUVIMEDSkopri EUVIMED
Crossref

Effect of a selective MAO-A inhibitor (Ro 41-1049) on striatal L-dopa and dopamine metabolism: An in vivo study

T Brannan, A Prikhojan, M D Yahr

Journal of Neural Transmission - Parkinson's Disease and Dementia Section · 1994

DOI: 10.1007/bf02250920 ↗

At a glance

Journal article in Journal of Neural Transmission - Parkinson's Disease and Dementia Section, 1994. Written by T Brannan and 2 co-authors. Institution: Department of Neurology, Mount Sinai School of Medicine, New York, NY. Cited 1 times so far (Crossref); 19 references.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

We administered Ro 41-1049, an inhibitor of the enzyme monoamine oxidase type A (MAO-A) to rats and monitored extracellular catecholamine levels in the corpus striatum before and after the intraperitoneal (IP) administration of a bolus of L-dopa. Acute administration of Ro 41-1049 (1-50 mg/kg IP) produced a dose-dependent decrease in basal levels of the dopamine metabolites 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) and an increase in basal levels of dopamine. In rats treated with Ro 41-1049 (20 mg/kg IP), L-dopa administration (100 mg/kg IP) produced a greater increase in striatal levels of dopamine than it did in controls, while DOPAC and HVA formation was attenuated. We conclude that inhibition of central MAO-A activity promotes synaptic accumulation of dopamine following administration of pharmacological doses of L-dopa.

Subjects

MeSH terms (MEDLINE)

3,4-Dihydroxyphenylacetic AcidAnimalsCatecholsCorpus StriatumDopamineDose-Response Relationship, DrugLevodopaMaleMonoamine Oxidase InhibitorsRatsRats, Sprague-DawleyThiazoles

Substances

CatecholsMonoamine Oxidase InhibitorsThiazoles3,4-Dihydroxyphenylacetic AcidRo 41-1049LevodopacatecholDopamine

Authors and institutions

  • Department of Neurology, Mount Sinai School of Medicine, New York, NY.

Cite

APA

Brannan, T., Prikhojan, A., & Yahr, M. D. (1994). Effect of a selective MAO-A inhibitor (Ro 41-1049) on striatal L-dopa and dopamine metabolism: An in vivo study. Journal of Neural Transmission - Parkinson's Disease and Dementia Section. https://doi.org/10.1007/bf02250920

Vancouver

Brannan T, Prikhojan A, Yahr MD. Effect of a selective MAO-A inhibitor (Ro 41-1049) on striatal L-dopa and dopamine metabolism: An in vivo study. Journal of Neural Transmission - Parkinson's Disease and Dementia Section. 1994. doi:10.1007/bf02250920

BibTeX
@article{Brannan1994,
  author = {Brannan, T and Prikhojan, A and Yahr, M D},
  title = {Effect of a selective MAO-A inhibitor (Ro 41-1049) on striatal L-dopa and dopamine metabolism: An in vivo study},
  journal = {Journal of Neural Transmission - Parkinson's Disease and Dementia Section},
  year = {1994},
  doi = {10.1007/bf02250920}
}
Start for free →